This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Cygnus Therapeutic Systems, Farmos Group Ltd., Cygnus, Inc.. Active years: 1992-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 23 
2 out of 10 
1 out of 75 Years Active: 1992-1998
Title: **Innovator Spotlight: Donald R. Wilson**
Introduction
Donald R. Wilson is a prominent inventor based in San Francisco, CA, known for his significant contributions to the field of transdermal drug delivery systems. With a robust portfolio of four patents, Wilson's innovations are making a substantial impact on the medical and pharmaceutical industries.
Latest Patents
Among his latest patents is a sophisticated **Device for administering drug transdermally with a controlled temporal** release. This device effectively provides an initial dose of medication followed by a continuous lower rate of delivery. The invention comprises a drug reservoir containing the drug dissolved in a carrier, along with a volatile permeation enhancer. This enhancer is strategically confined between a backing that allows vapor passage and a substrate layer permeable to the drug, carrier, and enhancer. When applied to the skin, the volatile permeation enhancer evaporates through the backing, controlling the dosage's initial magnitude and duration based on the backing's permeability.
Career Highlights
Wilson's career has been marked by his association with leading companies in the healthcare sector, including Cygnus Therapeutic Systems and Farmos Group Ltd. His work at these companies has underscored his dedication to advancing therapeutic delivery methods, directly benefiting patients requiring medication.
Collaborations
Throughout his career, Wilson has had the opportunity to collaborate with esteemed colleagues, including Renee A. Fallon and Kenneth J. Colley. These collaborations have played a vital role in fostering innovation and enhancing the effectiveness of his inventions.
Conclusion
Donald R. Wilson's contributions to transdermal drug delivery reflect his commitment to improving patient care through innovative solutions. His patents not only showcase his inventive prowess but also signify a step forward in medical technology, aimed at enhancing the way medications are administered to patients. As he continues to develop groundbreaking solutions, the impact of his work will undoubtedly resonate in the healthcare community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile